Intravesical administration of pirarubicin against superficial bladder cancer: Relationship between tumor tissue concentration and exposure time in the bladder or therapeutic effect-Reference-Cited by-同舟云学术

Intravesical administration of pirarubicin against superficial bladder cancer: Relationship between tumor tissue concentration and exposure time in the bladder or therapeutic effect

Published:2011 Issue:5 Volume:2 Page:901-905
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:en
Short-container-title:

Author:

ARAKAWA MAKI,NAKAMURA KOGENTA,YAMADA YOSHIAKI,KATO KIMIHITO,KATSUDA REMI,TOBIUME MOTOI,ZENNAMI KENJI,WATANABE MASAYUKI,KATO YOSHIHARU,NISHIKAWA GENYA,YOSHIZAWA TAKAHIKO,AOKI SHIGEYUKI,TAKI TOMOHIRO,MITSUI KENJI,HONDA NOBUAKI,SAITO HIROKO,HASEGAWA TAKAAKI

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Homologous Targeting and Adhesion Abilities of Cellular Microvesicles for Enhanced Intravesical Therapy of Bladder Cancer;Advanced Therapeutics;2023-12-15

2. Comparison of the Efficacy of Postoperative Gemcitabine versus Pirarubicin Perfusion Chemotherapy for Non-Muscle Invasive Bladder Cancer;Advances in Clinical Medicine;2023

3. Safety Assessment of Ultrasound-Assisted Intravesical Chemotherapy in Normal Dogs: A Pilot Study;Frontiers in Pharmacology;2022-03-18

4. Preparation, characterization and evaluation of [125I]-pirarubicin: A new therapeutic agent for urinary bladder cancer with potential for use as theranostic agent;Applied Radiation and Isotopes;2022-01

5. Efficacy of Bladder Intravesical Chemotherapy with Three Drugs for Preventing Non-Muscle-Invasive Bladder Cancer Recurrence;Journal of Healthcare Engineering;2021-11-30